Effectiveness of Autologous Platelet-rich Plasma after Endoscopic Submucosal Dissection

Effect of autologous platelet rich plasma for on post-endoscopic submucosal dissection wound

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003753

Enrollment

Registered

2019-04-12

Start date

2017-09-01

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Autologous platelet rich plasma, total 4ml, frequency (once), local injection. All participants were injected intravenous PPI for first 3 days and took PPI orally during follow up days for up t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged 20 to 65 years

Exclusion criteria

Exclusion criteria: Patients who refused to provide consent, uncontrolled cardiopulmonary disease, mental illness, severe infection, stomach/esophageal surgery, performance status of 2 or more, decrease in absolute neutrophil count, kidney failure, liver failure, steroid users, anemia , Platelet reducers

Design outcomes

Primary

Measure	Time frame
size and stage of ulcer	—

Secondary

Measure	Time frame
rate of acute complications	—

Countries

Korea, Republic of

Contacts

Public ContactInkyung Yoo

Korea University Anam Hospital

Outcome results